The virus-immunity ecosystem.

P C Doherty, S J Turner
Author Information
  1. P C Doherty: Department of Microbiology and Immunology, University of Melbourne, Victoria, Australia. pcd@unimelb.edu.au

Abstract

The ecology of pathogenic viruses can be considered both in the context of survival in the macro-environments of nature, the theme pursued generally by epidemiologists, and in the micro-environments of the infected host. The long-lived, complex, higher vertebrates have evolved specialized, adaptive immune systems designed to minimise the consequences of such parasitism. Through evolutionary time, the differential selective pressures exerted variously by the need for virus and host survival have shaped both the "one-host" viruses and vertebrate immunity. With the development of vaccines to protect us from many of our most familiar parasites, the most dangerous pathogens threatening us now tend to be those "emerging", or adventitious, infectious agents that sporadically enter human populations from avian or other wild-life reservoirs. Such incursions must, of course, have been happening through the millenia, and are likely to have led to the extraordinary diversity of recognition molecules, the breadth in effector functions, and the persistent memory that distinguishes the vertebrate, adaptive immune system from the innate response mechanisms that operate more widely through animal biology. Both are important to contemporary humans and, particularly in the period immediately following infection, we still rely heavily on an immediate response capacity, elements of which are shared with much simpler, and more primitive organisms. Perhaps we will now move forward to develop useful therapies that exploit, or mimic, such responses. At this stage, however, most of our hopes for minimizing the threat posed by viruses still focus on the manipulation of the more precisely targeted, adaptive immune system.

References

  1. J Exp Med. 2003 Oct 6;198(7):1011-21 [PMID: 14517272]
  2. J Comp Pathol. 1971 Oct;81(4):537-43 [PMID: 5002722]
  3. Nature. 2003 Mar 27;422(6930):428-33 [PMID: 12660783]
  4. Nat Med. 2003 Sep;9(9):1131-7 [PMID: 12925846]
  5. Nat Immunol. 2004 Mar;5(3):233-6 [PMID: 14985706]
  6. Immunity. 1998 Jun;8(6):683-91 [PMID: 9655482]
  7. J Immunol. 2002 Nov 15;169(10):5827-37 [PMID: 12421964]
  8. J Immunol. 2003 Nov 15;171(10):4969-73 [PMID: 14607890]
  9. J Immunol. 1997 Dec 1;159(11):5197-200 [PMID: 9548456]
  10. J Virol. 2003 Nov;77(22):12252-65 [PMID: 14581562]
  11. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15565-70 [PMID: 9861009]
  12. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5135-40 [PMID: 10220431]
  13. J Virol. 1994 Sep;68(9):6083-6 [PMID: 8057487]
  14. Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2017-22 [PMID: 14764895]
  15. Eur J Immunol. 2002 Aug;32(8):2117-23 [PMID: 12209623]
  16. Curr Opin Immunol. 1997 Aug;9(4):453-5 [PMID: 9287182]
  17. J Immunol Methods. 2003 Dec;283(1-2):141-53 [PMID: 14659906]
  18. J Neuroimmunol. 1993 Jul;46(1-2):11-7 [PMID: 8103060]
  19. Nat Med. 2001 Aug;7(8):913-9 [PMID: 11479623]
  20. J Immunol. 2002 Jul 15;169(2):739-49 [PMID: 12097376]
  21. Curr Rheumatol Rep. 2003 Aug;5(4):255-63 [PMID: 14531952]
  22. J Immunol. 1996 Dec 1;157(11):5049-60 [PMID: 8943414]
  23. J Virol. 1994 Dec;68(12):8056-63 [PMID: 7966595]
  24. J Mol Biol. 2003 Nov 14;334(1):103-18 [PMID: 14596803]
  25. J Immunol. 2003 May 15;170(10):5018-26 [PMID: 12734346]
  26. J Gen Virol. 1998 Feb;79 ( Pt 2):353-61 [PMID: 9472620]
  27. Structure. 1994 Aug 15;2(8):733-46 [PMID: 7994573]
  28. Blood. 2003 Aug 1;102(3):849-57 [PMID: 12689947]
  29. J Mol Biol. 2003 Jul 25;330(5):1101-15 [PMID: 12860131]
  30. Clin Immunol. 2002 Nov;105(2):117-25 [PMID: 12482386]
  31. J Infect Dis. 2004 Jan 15;189(2):221-32 [PMID: 14722886]
  32. Immunol Rev. 1996 Apr;150:23-44 [PMID: 8782700]
  33. J Exp Med. 2000 Feb 7;191(3):573-8 [PMID: 10662803]
  34. Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9281-6 [PMID: 10430934]
  35. J Immunol. 2003 Jul 1;171(1):27-31 [PMID: 12816979]
  36. J Immunol. 2000 Mar 15;164(6):3274-82 [PMID: 10706720]
  37. Scand J Immunol. 1989 Oct;30(4):425-34 [PMID: 2554488]
  38. Annu Rev Immunol. 2000;18:561-92 [PMID: 10837069]
  39. Am J Pathol. 2001 Oct;159(4):1219-24 [PMID: 11583948]
  40. J Clin Invest. 1989 Oct;84(4):1174-80 [PMID: 2551924]
  41. Immunol Rev. 1999 Feb;167:5-15 [PMID: 10319247]
  42. Nat Immunol. 2002 Jun;3(6):529-35 [PMID: 12021778]
  43. Immunol Rev. 1997 Oct;159:105-17 [PMID: 9416506]
  44. J Immunol. 2000 Dec 1;165(11):6081-90 [PMID: 11086040]
  45. Cell. 1994 Jun 17;77(6):791-3 [PMID: 8004668]
  46. J Exp Med. 1998 Dec 21;188(12):2205-13 [PMID: 9858507]
  47. Curr Opin Immunol. 1993 Aug;5(4):479-83 [PMID: 8216921]
  48. Nature. 1993 Apr 22;362(6422):758-61 [PMID: 8469287]
  49. J Immunol. 2003 Oct 15;171(8):4140-8 [PMID: 14530336]
  50. Immunol Rev. 1999 Apr;168:103-20 [PMID: 10399068]
  51. Nature. 1998 Jun 4;393(6684):474-8 [PMID: 9624003]
  52. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8732-7 [PMID: 11447288]
  53. Immunity. 2000 May;12(5):451-7 [PMID: 10843378]
  54. Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14145-50 [PMID: 14610278]
  55. J Med Virol. 2004 Apr;72(4):688-94 [PMID: 14981775]
  56. FASEB J. 1998 Oct;12(13):1255-65 [PMID: 9761770]
  57. J Gen Virol. 2002 Oct;83(Pt 10):2497-2505 [PMID: 12237433]
  58. J Exp Med. 2002 Mar 4;195(5):657-64 [PMID: 11877489]
  59. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7235-40 [PMID: 12775762]
  60. J Gen Virol. 2001 Aug;82(Pt 8):1971-1981 [PMID: 11458005]
  61. Curr Opin Immunol. 2003 Oct;15(5):516-21 [PMID: 14499259]
  62. Virology. 1999 Jul 5;259(2):256-61 [PMID: 10388649]
  63. Immunity. 2002 Jul;17(1):1-6 [PMID: 12150886]
  64. Eur J Immunol. 2003 May;33(5):1174-82 [PMID: 12731042]
  65. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8597-602 [PMID: 10411921]
  66. Annu Rev Med. 2002;53:499-518 [PMID: 11818487]
  67. J Immunol. 2011 Jul 1;187(1):7-9 [PMID: 21690331]
  68. J Virol. 1994 Jun;68(6):3486-90 [PMID: 7514676]
  69. J Exp Med. 1993 Nov 1;178(5):1725-32 [PMID: 8228818]
  70. Neurology. 2000 Mar 28;54(6):1227-32 [PMID: 10746589]
  71. J Immunol. 2003 Jan 1;170(1):147-52 [PMID: 12496394]
  72. Microbes Infect. 2003 Apr;5(5):439-48 [PMID: 12738000]
  73. J Virol. 1998 Jan;72(1):882-5 [PMID: 9420305]
  74. Nat Immunol. 2003 Dec;4(12):1191-8 [PMID: 14625547]
  75. J Exp Med. 1999 May 17;189(10):1555-64 [PMID: 10330434]
  76. Immunity. 2003 Apr;18(4):549-59 [PMID: 12705857]
  77. Nature. 1994 Jun 23;369(6482):652-4 [PMID: 7516039]
  78. Nat Rev Immunol. 2003 May;3(5):361-70 [PMID: 12766758]
  79. Transplant Rev. 1974;19(0):89-120 [PMID: 4601807]
  80. Curr Opin Immunol. 2001 Aug;13(4):442-50 [PMID: 11498300]
  81. Nature. 2002 Jan 17;415(6869):335-9 [PMID: 11797012]
  82. Science. 2001 Jul 13;293(5528):303-6 [PMID: 11452126]
  83. Curr Opin Immunol. 2003 Aug;15(4):443-9 [PMID: 12900277]
  84. Proc Natl Acad Sci U S A. 2001 May 22;98(11):6313-8 [PMID: 11344265]
  85. Curr Opin Immunol. 2003 Jun;15(3):336-42 [PMID: 12787761]
  86. Adv Virus Res. 2003;60:421-67 [PMID: 14689700]
  87. J Virol. 1995 Mar;69(3):1895-902 [PMID: 7853531]
  88. J Immunol. 2000 Feb 15;164(4):1820-8 [PMID: 10657630]
  89. Viral Immunol. 2001;14(4):403-13 [PMID: 11792069]
  90. Vaccine. 2003 Jun 2;21(19-20):2616-26 [PMID: 12744898]
  91. J Infect Dis. 1994 Nov;170(5):1189-94 [PMID: 7963712]
  92. Science. 2001 Jul 13;293(5528):245-8 [PMID: 11452113]
  93. Adv Virus Res. 2003;61:373-91 [PMID: 14714437]
  94. Curr Opin Immunol. 1998 Jun;10(3):252-8 [PMID: 9638360]
  95. Lancet. 1975 Jun 28;1(7922):1406-9 [PMID: 49564]
  96. Adv Immunol. 1999;73:1-77 [PMID: 10399005]
  97. J Gen Virol. 2003 Feb;84(Pt 2):337-341 [PMID: 12560565]
  98. Immunol Rev. 1997 Oct;159:155-61 [PMID: 9416509]
  99. Science. 1999 Nov 12;286(5443):1377-81 [PMID: 10558996]
  100. Virology. 2003 Sep 1;313(2):387-400 [PMID: 12954207]
  101. Science. 1999 Oct 29;286(5441):958-61 [PMID: 10542151]
  102. Microbiol Rev. 1992 Mar;56(1):152-79 [PMID: 1579108]
  103. Immunol Rev. 1995 Feb;143:141-80 [PMID: 7558075]
  104. Annu Rev Immunol. 1996;14:101-30 [PMID: 8717509]
  105. J Immunol. 2001 Apr 1;166(7):4627-33 [PMID: 11254721]
  106. Science. 2000 Oct 20;290(5491):486-92 [PMID: 11039923]
  107. J Virol. 1999 Feb;73(2):1453-9 [PMID: 9882351]
  108. J Immunol. 2003 Aug 15;171(4):1684-90 [PMID: 12902466]
  109. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11802-7 [PMID: 12192093]
  110. J Exp Med. 1996 Sep 1;184(3):863-71 [PMID: 9064346]
  111. J Virol. 2000 Dec;74(24):11690-6 [PMID: 11090168]
  112. J Neuroimmunol. 2002 Feb;123(1-2):35-40 [PMID: 11880147]
  113. J Virol. 2002 Dec;76(23):12388-93 [PMID: 12414983]
  114. Eur J Immunol. 2002 Jun;32(6):1567-73 [PMID: 12115639]
  115. J Infect Dis. 2001 Nov 15;184(10):1268-78 [PMID: 11679915]
  116. Ann N Y Acad Sci. 1994 Dec 15;740:138-45 [PMID: 7840445]
  117. Acta Haematol. 1958 Jul-Oct;20(1-4):1-8 [PMID: 13582541]
  118. J Immunol. 2002 Apr 1;168(7):3477-83 [PMID: 11907108]
  119. Nat Rev Immunol. 2003 Apr;3(4):269-79 [PMID: 12669018]
  120. J Infect Dis. 1989 Jun;159(6):1119-22 [PMID: 2786041]
  121. J Exp Med. 1997 Jul 7;186(1):65-70 [PMID: 9206998]
  122. Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):475-88 [PMID: 11313006]
  123. Virology. 2000 Aug 15;274(1):94-104 [PMID: 10936092]
  124. J Virol. 2002 Jun;76(12):6138-46 [PMID: 12021347]
  125. J Virol. 2000 May;74(9):3996-4003 [PMID: 10756011]
  126. J Immunol. 1999 Jun 15;162(12):7578-83 [PMID: 10358215]
  127. J Infect Dis. 2003 Nov 15;188(10):1562-70 [PMID: 14624383]
  128. J Exp Med. 1997 Dec 15;186(12):2063-8 [PMID: 9396777]
  129. Immunol Rev. 1999 Dec;172:97-108 [PMID: 10631940]
  130. J Comp Pathol. 1971 Oct;81(4):545-9 [PMID: 4944376]
  131. J Immunol Methods. 2002 Dec 20;271(1-2):137-51 [PMID: 12445737]
  132. J Immunol Methods. 2004 Jan;284(1-2):89-97 [PMID: 14736419]
  133. Med J Aust. 1972 May 20;1(21):1083-4 [PMID: 5040017]
  134. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2657-62 [PMID: 12601154]
  135. J Exp Med. 2002 Feb 4;195(3):283-93 [PMID: 11828003]
  136. Vaccine. 2003 Jun 1;21 Suppl 2:S68-76 [PMID: 12763686]

MeSH Term

Animals
Ecosystem
Humans
Immunity, Active
Immunity, Innate
Immunologic Memory
Virus Diseases

Word Cloud

Created with Highcharts 10.0.0virusesadaptiveimmunesurvivalhostvertebrateusnowsystemresponsestillecologypathogeniccanconsideredcontextmacro-environmentsnaturethemepursuedgenerallyepidemiologistsmicro-environmentsinfectedlong-livedcomplexhighervertebratesevolvedspecializedsystemsdesignedminimiseconsequencesparasitismevolutionarytimedifferentialselectivepressuresexertedvariouslyneedvirusshaped"one-host"immunitydevelopmentvaccinesprotectmanyfamiliarparasitesdangerouspathogensthreateningtend"emerging"adventitiousinfectiousagentssporadicallyenterhumanpopulationsavianwild-lifereservoirsincursionsmustcoursehappeningmillenialikelyledextraordinarydiversityrecognitionmoleculesbreadtheffectorfunctionspersistentmemorydistinguishesinnatemechanismsoperatewidelyanimalbiologyimportantcontemporaryhumansparticularlyperiodimmediatelyfollowinginfectionrelyheavilyimmediatecapacityelementssharedmuchsimplerprimitiveorganismsPerhapswillmoveforwarddevelopusefultherapiesexploitmimicresponsesstagehoweverhopesminimizingthreatposedfocusmanipulationpreciselytargetedvirus-immunityecosystem

Similar Articles

Cited By